FDA Fast Track designation supports accelerated development and expedites regulatory reviewNorovirus is responsible for an ...

The Food and Drug Administration (FDA) has granted Fast Track designation to CDI-988 for treatment and prophylaxis of norovirus infection.

CDI-988 was designed and developed as an inhibitor of a highly conserved region of noroviruses, coronaviruses, and other 3CL viral proteases. A Phase 1b norovirus challenge study is underway at Emory ...

A newly approved pill form of GLP-1 medication could revolutionize obesity treatment by offering a convenient alternative to ...

A highly mutated COVID variant known as “Cicada” is spreading across multiple states in the U.S., and health experts are ...

"We are pleased that the FDA has granted Fast Track designation for CDI-988, marking a significant milestone for Cocrystal ...

A nasty stomach virus has taken over Spain's Costa del Sol region, and British tourists are being warned, during their Easter ...

Sidney Lumet’s kinetic, emotionally complex film has been transformed into a hokey sitcom with gunshots.

The U.S. Food and Drug Administration has approved Eli Lilly's once-daily oral weight-loss pill, setting the stage for a ...

While most backpackers treat water, a vocal minority—and a viral article—insist it’s overkill. But new evidence suggests backcountry water contamination may be more widespread than we thought.

Dose-Dependent Efficacy Results : As of the latest data cut, muzastotugachieved a 31% (8/26) confirmed overall response rate (ORR) in the combined 20 mg/kg dose cohorts, showing a clear improvement ...